02.04.2014 18:00:00

Italian Branch of Global Pharma Leader Deploys Cegedim Relationship Management’s OneKey Database to Optimize Targeting Strategies

Cegedim Relationship Management today announced that Novartis Farma has implemented OneKey to maximize its wide-ranging commercial activity in Italy. As the industry’s most comprehensive, freshly-updated, and compliant healthcare professional (HCP) and organization database, OneKey provides Novartis Farma with a clear understanding of Italy’s local and regional healthcare structure. Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines, over-the-counter and animal health products.

Next Generation Database Provides New Value and Stakeholder Intelligence in Italian Market
Cegedim Relationship Management’s OneKey includes 13.7 million registered HCPs worldwide – each aggregated by affiliation, specialty and organization. Novartis Farma can benefit from OneKey’s rich capability to seamlessly adapt to Italy’s data privacy laws – expertly ensuring continued compliance. Further, OneKey features the most superior data quality via systematic phone validation, real time updates, consistent database cleansing, and constant inflow of new customer information.

Novartis Farma decided to expand their existing relationship with Cegedim because of Cegedim’s proven expertise in Italy; along with the exceptional breadth and quality of OneKey, acknowledging the database’s flexibility, as it easily integrates with their current CRM system. Novartis Farma’s OneKey subscription level includes Market Access data and Master Data Management (MDM) services to consolidate disparate data sources.

"OneKey allows Novartis Farma to strengthen CRM efficiency with the optimal coverage of registered HCPs – consistently updated by our in-house database specialists,” explained Stefan Janssens, President EMEA & APAC, Cegedim Relationship Management. "OneKey was specifically designed to help our customers generate new intelligence on their target markets and stakeholder networks, leveraging full compliance and transparency in database management. We’re proud that we can now count Novartis Farma among our many OneKey customers.”

     
About Cegedim Relationship Management:  

Cegedim Relationship Management is the Life Sciences industry’s leading provider of Customer Relationship Management (CRM) solutions. Designed specifically for Life Sciences, the company’s innovative business solutions incorporate a thorough understanding of local, regional and worldwide trends. Cegedim Relationship Management enables approximately 200,000 users in many of the world’s most innovative companies to stay ahead of market challenges. In addition to CRM, Cegedim Relationship Management also provides marketing, data optimization and regulatory compliance solutions in more than 80 countries. Cegedim Relationship Management is part of the France-based Cegedim S.A. Group.


To learn more, please visit:

www.CegedimRM.com.

Follow Cegedim Relationship Management on LinkedIn and Twitter.

 
About Cegedim:   Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, life sciences companies, healthcare professionals and insurance companies. The world leader in life sciences CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data. Cegedim employs 8,000 people in more than 80 countries and generated revenue of €902 million in 2013. Cegedim SA is listed in Paris (EURONEXT: CGM).


To learn more, please visit: www.cegedim.com.

And follow Cegedim on Twitter: @CegedimGroup.

Nachrichten zu Cegedim S.A.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Cegedim S.A.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Cegedim S.A. 11,75 -10,98% Cegedim S.A.